Pascal Gauduchon

4.1k total citations
107 papers, 3.2k citations indexed

About

Pascal Gauduchon is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Pascal Gauduchon has authored 107 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 34 papers in Cancer Research and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Pascal Gauduchon's work include Carcinogens and Genotoxicity Assessment (17 papers), Cell death mechanisms and regulation (12 papers) and RNA Interference and Gene Delivery (11 papers). Pascal Gauduchon is often cited by papers focused on Carcinogens and Genotoxicity Assessment (17 papers), Cell death mechanisms and regulation (12 papers) and RNA Interference and Gene Delivery (11 papers). Pascal Gauduchon collaborates with scholars based in France, Luxembourg and United States. Pascal Gauduchon's co-authors include Laurent Poulain, Ph. Wahl, François Sichel, E. Deslandes, Pierre Lebailly, Cathy Staedel, Thierry Godard, Franck Carreiras, Émilie Brotin and Christophe Denoyelle and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Experimental Medicine and Blood.

In The Last Decade

Pascal Gauduchon

107 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pascal Gauduchon France	37	1.7k	999	642	345	292	107	3.2k
Georg Krupitza Austria	33	2.7k 1.6×	853 0.9×	1.4k 2.1×	241 0.7×	150 0.5×	134	5.0k
Manfred F. Rajewsky Germany	38	2.9k 1.7×	1.5k 1.5×	799 1.2×	206 0.6×	76 0.3×	172	4.7k
Michael Grusch Austria	41	2.9k 1.7×	783 0.8×	1.1k 1.7×	303 0.9×	83 0.3×	161	4.7k
Moulay A. Alaoui‐Jamali Canada	42	3.1k 1.9×	792 0.8×	1.3k 2.0×	277 0.8×	258 0.9×	138	4.8k
Joseph Fargnoli United States	34	2.3k 1.4×	627 0.6×	750 1.2×	177 0.5×	156 0.5×	56	3.9k
Herbert D. Soule United States	18	3.1k 1.8×	911 0.9×	1.8k 2.8×	291 0.8×	257 0.9×	31	5.1k
Gennadi V. Glinsky United States	32	2.8k 1.6×	825 0.8×	1.0k 1.6×	174 0.5×	156 0.5×	75	4.1k
James L. Wittliff United States	34	1.5k 0.9×	881 0.9×	1.2k 1.9×	323 0.9×	78 0.3×	164	4.1k
Chris van Bree Netherlands	18	2.3k 1.4×	793 0.8×	1.2k 1.8×	178 0.5×	47 0.2×	47	4.4k
J. Justin McCormick United States	40	3.7k 2.2×	1.9k 1.9×	945 1.5×	217 0.6×	95 0.3×	131	5.1k

Countries citing papers authored by Pascal Gauduchon

Since Specialization

Citations

This map shows the geographic impact of Pascal Gauduchon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Gauduchon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Gauduchon more than expected).

Fields of papers citing papers by Pascal Gauduchon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Gauduchon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Gauduchon. The network helps show where Pascal Gauduchon may publish in the future.

Co-authorship network of co-authors of Pascal Gauduchon

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Gauduchon. A scholar is included among the top collaborators of Pascal Gauduchon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Gauduchon. Pascal Gauduchon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ahmad, Mohammad, Pierre‐Marie Morice, Bernard Lambert, et al.. (2021). The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels. Molecular Oncology. 15(12). 3659–3678. 32 indexed citations

Vernon, Mégane, Bernard Lambert, Matthieu Meryet‐Figuière, et al.. (2020). Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids. Molecular Cancer Therapeutics. 19(7). 1506–1519. 23 indexed citations

Villedieu, Marie, Émilie Brotin, Marie-Hélène Louis, et al.. (2014). PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced. Cancer Letters. 348(1-2). 38–49. 43 indexed citations

Malzert‐Fréon, Aurélie, Florence Giffard, Émilie Brotin, et al.. (2013). Sensitization of ovarian carcinoma cells to Bcl-xL-targeting strategies through indirect modulation of Mcl-1 activity by MR22388, a molecule of the tripentone family. Journal of Ovarian Research. 6(1). 38–38. 4 indexed citations

Lincet, Hubert, Blandine Guével, Charles Pineau, et al.. (2011). Comparative 2D-DIGE proteomic analysis of ovarian carcinoma cells: Toward a reorientation of biosynthesis pathways associated with acquired platinum resistance. Journal of Proteomics. 75(4). 1157–1169. 18 indexed citations

Denoyelle, Christophe, Émilie Brotin, Matthieu Meryet‐Figuière, et al.. (2010). Downregulation of Bcl-x L and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy. Carcinogenesis. 31(6). 984–993. 58 indexed citations

Brotin, Émilie, Matthieu Meryet‐Figuière, Raphaël E. Duval, et al.. (2009). Bcl‐X_L and MCL‐1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis. International Journal of Cancer. 126(4). 885–895. 86 indexed citations

Chantepie, Sylvain, Dominique Vaur, Christoph Grunau, et al.. (2009). ZAP-70 intron1 DNA methylation status: Determination by pyrosequencing in B chronic lymphocytic leukemia. Leukemia Research. 34(6). 800–808. 18 indexed citations

Lincet, Hubert, Paulo Marcelo, Natacha Heutte, et al.. (2007). A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment. PROTEOMICS. 7(22). 4090–4101. 20 indexed citations

10.

Roulland, Sandrine, Pierre Grenot, Michèle Milili, et al.. (2006). Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. The Journal of Experimental Medicine. 203(11). 2425–2431. 130 indexed citations

11.

Maubant, Sylvie, Séverine Cruet-Hennequart, Soizic Dutoit, et al.. (2005). Expression of α V-associated integrin β subunits in epithelial ovarian cancer andits relation to prognosis in patients treated with platinum-based regimens. The Histochemical Journal. 36(1-2). 119–129. 24 indexed citations

12.

Jaffré, Anne, Isabelle Baldi, A. Vital, et al.. (2005). Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents. Mutagenesis. 20(5). 365–373. 10 indexed citations

13.

Maubant, Sylvie, Séverine Cruet-Hennequart, Laurent Poulain, et al.. (2001). Altered adhesion properties and alpha v integrin expression in a cisplatin‐resistant human ovarian carcinoma cell line. International Journal of Cancer. 97(2). 186–194. 43 indexed citations

14.

Lincet, Hubert, Laurent Poulain, Jean-Serge Rémy, et al.. (2000). The p21 cip1/waf1 cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Cancer Letters. 161(1). 17–26. 84 indexed citations

15.

Florent, Martine, Thierry Godard, Jean-Jacques Ballet, Pascal Gauduchon, & Brigitte Sola. (1999). Detection by the comet assay of apoptosis induced in lymphoid cell lines after growth factor deprivation. Cell Biology and Toxicology. 15(3). 185–192. 28 indexed citations

16.

Lebailly, Pierre, C. Vigreux, Thierry Godard, et al.. (1997). Assessment of DNA damage induced in vitro by etoposide and two fungicides (carbendazim and chlorothalonil) in human lymphocytes with the comet assay. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 375(2). 205–217. 62 indexed citations

17.

Dallemagne, Patrick, et al.. (1994). Synthesis and Cytotoxic Activity against L1210 Leukemia of New Aminocyclopenta(c)thiophenones.. Chemical and Pharmaceutical Bulletin. 42(8). 1605–1608. 8 indexed citations

18.

Lewin, Guy, et al.. (1992). Cytotoxicite de Dimeres a Squelette Chalcane. Journal of Natural Products. 55(11). 1679–1681. 1 indexed citations

19.

Malas, Jean-Paul, et al.. (1990). Alteration in isoenzyme patterns of serum galactosyltransferase activity in ovarian cancer patients: preliminary results. Biomedicine & Pharmacotherapy. 44(6). 325–331. 2 indexed citations

20.

Gauduchon, Pascal, et al.. (1983). Clinical value of serum glycoprotein galactosyltransferase levels in different histological types of ovarian carcinoma.. PubMed. 43(9). 4491–6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact